Business UpdateMay 27, 2026, 08:32 AM
TOMI Highlights SteraMist Relevance Amid Rising Global Disease Threats
AI Summary
TOMI Environmental Solutions, Inc. highlighted the growing commercial relevance of its SteraMist platform due to escalating global concerns over infectious disease outbreaks, including the Ebola emergency in Central Africa and new CDC-backed hantavirus research in the U.S. A peer-reviewed study found high exposure rates to Sin Nombre virus in rodents across major U.S. agricultural regions, reinforcing airborne and surface contamination risks. TOMI believes these converging threats will accelerate demand for its EPA-registered decontamination technologies, noting its past success in helping contain an Ebola outbreak in West Africa with SteraMist.
Key Highlights
- WHO warns of rapidly spreading Ebola outbreak in Central Africa.
- CDC journal study found nearly 30% of US agricultural rodents exposed to hantavirus.
- Approximately 10% of sampled rodents carried active hantavirus infections.
- TOMI's SteraMist platform addresses pathogen threats in complex indoor environments.
- TOMI previously deployed SteraMist to help contain an Ebola outbreak in West Africa.
- SteraMist uses Binary Ionization Technology (BIT) with ionized Hydrogen Peroxide (iHP).
- Increased global pathogen threats could accelerate demand for SteraMist.
Price Impact
More from TOMZ